Orange Book product · Generic (ANDA)
CARBOPROST TROMETHAMINE
CARBOPROST TROMETHAMINE
At a glance
Jan 27, 2022
Approved
Generic (ANDA)
Application
AP
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jan 27, 2022
4 yr 5 mo ago
Today
Pharmaceutical detail
Active ingredient
CARBOPROST TROMETHAMINE
Strength
EQ 0.25MG BASE/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
AP
Application
ANDA 215337
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of CARBOPROST TROMETHAMINE
- —HEMABATEBrand (NDA)
NDA 017989 · PFIZER
- 2026CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 219529 · SOMERSET THERAPS LLC
- 2024CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 218013 · MICRO LABS
- 2024CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 215901 · ANI PHARMS
- 2023CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 217657 · GLAND
- 2023CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 216897 · ONESOURCE SPECIALTY
- 2023CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 217198 · ALEMBIC
- 2023CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 216939 · EUGIA PHARMA
- 2023CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 216824 · SOLA PHARMS
- 2023CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 216882 · CAPLIN
- 2022CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 214499 · LONG GROVE PHARMS
- 2021CARBOPROST TROMETHAMINEGeneric (ANDA)
ANDA 213118 · SUNNY
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
